Skip to main content

Table 4 Hazard ratio (HRs) and 95% confidence intervals (CIs) of total mortality according to PG-SGA and NUTRISCORE among patients who received all three consultations

From: Associations of patient-generated subjective global assessment (PG-SGA) and NUTRISCORE with survival in gastric cancer patients: timing matters, a retrospective cohort study

By time point

PG-SGA

NUTRISCORE

≤ 5

6–8

9–11

≥ 12

P for trend

≤ 4

5

6

≥ 7

P for trend

1st nutritional consultation

 N (score means ± SD)

26 (3.2 ± 1.4)

41

(7.2 ± 0.8)

35 (10.1 ± 0.9)

43 (15.5 ± 3.5)

 

32 (4.0 ± 0.0)

86 (5.0 ± 0.0)

98 (6.0 ± 0.0)

62 (7.1 ± 0.4)

 

 No. of cases/person-years

8/125.0

9/235.4

7/199.3

10/239.1

 

13/156.5

17/483.0

16/548.3

16/327.5

 

  Model 1a

1.00

0.60 (0.23–1.57)

0.56 (0.20–1.54)

0.69 (0.27–1.79)

0.571

1.00

0.43 (0.21–0.90)

0.37 (0.18–0.77)

0.59 (0.28–1.25)

0.299

  Model 2b

1.00

0.58 (0.22–1.52)

0.57 (0.20–1.58)

0.56 (0.21–1.48)

0.324

1.00

0.41 (0.20–0.87)

0.36 (0.17–0.74)

0.46 (0.22–0.97)

0.108

  Model 3c

1.00

0.59 (0.22–1.60)

0.56 (0.19–1.61)

0.80 (0.28–2.25)

0.752

1.00

0.44 (0.20–0.96)

0.52 (0.22–1.25)

0.86 (0.32–2.31)

0.921

2nd nutritional consultation

 N (score means ± SD)

54 (3.0 ± 1.3)

32

(6.9 ± 0.8)

28 (10.1 ± 0.9)

31 (14.7 ± 2.8)

 

113 (3.8 ± 0.4)

111 (5.0 ± 0.0)

50 (6.0 ± 0.0)

4 (7.8 ± 1.0)

 

 No. of cases/person-years

12/302.3

8/157.6

8/150.8

6/175.8

 

19/609.2

31/585.5

10/272.8

2/17.3

 

  Model 1a

1.00

1.30 (0.52–3.22)

1.40 (0.56–3.47)

0.94 (0.35–2.53)

0.904

1.00

1.76 (0.99–3.12)

1.28 (0.59–2.77)

5.00

(1.05–23.74)

0.119

  Model 2b

1.00

1.02 (0.38–2.71)

1.77 (0.65–4.79)

0.97 (0.34–2.76)

0.765

1.00

1.44 (0.80–2.60)

1.18 (0.53–2.62)

3.51

(0.71–17.44)

0.279

  Model 3c

1.00

1.12 (0.39–3.20)

2.12 (0.69–6.55)

1.08 (0.32–3.62)

0.639

1.00

1.79 (0.94–3.39)

1.78 (0.70–4.57)

9.86

(1.46–66.76)

0.057

3rd nutritional consultation

 N (score means ± SD)

26 (3.3 ± 1.1)

25

(7.1 ± 0.7)

29 (10.1 ± 0.9)

65 (15.2 ± 2.9)

 

85 (3.7 ± 0.4)

91 (5.0 ± 0.0)

81 (6.0 ± 0.0)

21 (7.0 ± 0.2)

 

 No. of cases/person-years

5/138.0

3/139.2

8/143.2

18/349.3

 

14/440.3

28/436.6

13/458.2

7/96.5

 

  Model 1a

1.00

0.59 (0.14–2.51)

1.90 (0.59–6.14)

1.65 (0.60–4.55)

0.150

1.00

1.99 (1.04–3.80)

0.94 (0.43–2.07)

2.04 (0.81–5.13)

0.564

  Model 2b

1.00

0.55 (0.13–2.35)

1.45 (0.44–4.84)

1.69 (0.60–4.70)

0.117

1.00

1.45 (0.75–2.81)

0.69 (0.32–1.52)

1.59 (0.61–4.13)

0.797

  Model 3c

1.00

0.68 (0.15–3.02)

1.77 (0.50–6.23)

2.47 (0.74–8.28)

0.050

1.00

1.81 (0.90–3.66)

1.24 (0.49–3.16)

3.72

(1.14–12.13)

0.130

  1. PG-SGA patient generated-subjective global assessment
  2. aModel 1 was adjusted for age at surgery and sex
  3. bModel 2 was adjusted for types of operation (STG or TG), and stages (stage I and II or stage III) in addition to variables in model 1
  4. cModel 3 was adjusted for weight loss (kg, continuous), body mass index (kg/m2, continuous), digestive symptoms (yes or no), and protein intake relative to requirement (≥75% or < 75%) at each nutritional consultation in additional to variables in model 2